跳至主要内容
临床试验/JPRN-UMIN000004541
JPRN-UMIN000004541已完成未知

Feasibility study of maintenance therapy of TS-1 for stage IV non-small cell lung cancer - Feasibility study of maintenance TS-1 for non-small cell lung cancer

Hiroshima University0 个研究点目标入组 30 人开始时间: 2010年11月11日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients with active interstitial pneumonia or pulmonary fibrosis recognized by chest X-ray. Patients with massive uncontrolled pleural effusion , ascites, or pericardial effusion. Patients having active other cancers. a serious or uncontrolled concomitant systematic disorder (ileus, interstitial pneumonia, pulmonary fibrosis, COPD, uncontrolled diabetes mellitus, cardiac infarction or unstable angina within 6 months.) Patients with active concomitant pregnancy. HIV or HBV-positive patients Inappropriate patients for this study judged by the physicians

研究者

相似试验

已完成
不适用
Feasibility study of TS-1 adjuvant therapy for resected biliary tract cancerBiliary tract cancer
JPRN-UMIN000009029Keio University School of Medicin50
已完成
2 期
A phase II study of maintenance therapy with WT1 peptide-based cancer vaccine following the first-line therapy for advanced-stage ovarian cancerOvarian cancer
JPRN-UMIN000011859Osaka university graduate school of medicine55
进行中(未招募)
1 期
Maintenance therapy with Trabectedin after combination therapy Liposomal Doxorubicin plus Trabectedin vs Liposomal Doxorubicin plus Trabectedin in patients affected by relapsed ovarian cancer.MedDRA version: 21.0Level: PTClassification code 10033160Term: Ovarian epithelial cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Ovarian cancer
EUCTR2017-000987-14-ITAZIENDA OSPEDALIERA PER L'EMERGENZA CANNIZZARO130
进行中(未招募)
1 期
Thymosin alpha 1 plus maintenance therapy with the Standard of Care (SoC) chemotherapy plus cisplatin (or carboplatin) in patients with metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR wild type.metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR wild typeMedDRA version: 20.0 Level: LLT Classification code 10064049 Term: Lung adenocarcinoma metastatic System Organ Class: 100000004864
EUCTR2015-005605-36-ITSCICLONE PHARMACEUTICALS ITALY S.R.L.140
已完成
不适用
The investigation for maintenance therapy by mesalazine enema after remission induction by budesonide form enema in patients with ulcerative colitis: Multicenter randomized controlled studyulcerative colitis
JPRN-UMIN000034016Hyogo College of Medicine84